Cosmos Health COSM
NASDAQ COSM
$0.25 0.00 (-0.71%)
At close: Sep 10, 2026 · 4:00 PM EDT

Cosmos Health (COSM) Share-based Compensation (2011 - 2026)

Cosmos Health's (COSM) quarterly Share-based Compensation came in at $8.1 million in Q2 2026, down 37.71% on a YoY basis from $12.9 million in Q2 2025, and down 37.71% quarter-over-quarter from $12.9 million in Q1 2026.

Analysis

Cosmos Health (COSM) Share-based Compensation (2011 - 2026) Analysis & Trends

Cosmos Health (COSM) has reported Share-based Compensation for 14 consecutive years, with $8.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Share-based Compensation fell 37.71% year-over-year to $8.1 million; the trailing twelve-month figure through Jun 2026 stood at $8.1 million (down 37.71% YoY), and the FY2025 full-year result was $12.9 million, changed 0.0% from the prior year.
  • Share-based Compensation retreated to $8.1 million in Q2 2026 per COSM's latest filing, from $12.9 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $13.4 million in Q3 2024 and bottomed at -$1.5 million in Q4 2025.
  • Historically, Share-based Compensation has averaged $5.5 million across 5 years, with a median of $3.4 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Share-based Compensation soared 196195.29% in 2023, then plunged 361.81% in 2025.
  • Over 5 years, Share-based Compensation stood at -$2820.0 in 2022, then jumped by 12987.45% to $363426.0 in 2023, then soared by 61.38% to $586512.0 in 2024, then slumped by 361.81% to -$1.5 million in 2025, then surged by 624.4% to $8.1 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $8.1 million, $12.9 million, and -$1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Teva Pharmaceutical Industries 42.33 Bn 38.68 Bn 2.15 Bn 40.00 Mn
2 Viatris 19.05 Bn 18.16 Bn 1.46 Bn 30.40 Mn
3 Dr Reddys Laboratories 9.76 Bn 9.58 Bn 396.53 Mn 1.02 Mn
4 Amneal Pharmaceuticals 5.38 Bn 5.25 Bn 334.51 Mn 176,000.00
5 Bausch Health Companies 2.27 Bn 436.38 Mn 2.10 Bn 54.00 Mn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn 2.92 Mn
7 Ani Pharmaceuticals 1.51 Bn 1.15 Bn 165.89 Mn 11.41 Mn
8 Amphastar Pharmaceuticals 1.03 Bn 737.26 Mn 93.47 Mn 29.30 Mn
9 Fennec Pharmaceuticals 393.12 Mn 351.87 Mn 17.15 Mn 7.04 Mn
10 Cosmos Health 15.08 Mn 12.63 Mn 1.51 Mn 8.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.05 Mn
Mar 31, 2026 12.93 Mn
Dec 31, 2025 -1.54 Mn
Sep 30, 2025 12.93 Mn
Jun 30, 2025 12.93 Mn
Mar 31, 2025 12.93 Mn
Dec 31, 2024 586,512.00
Sep 30, 2024 13.43 Mn
Jun 30, 2024 8.56 Mn
Mar 31, 2024 340,194.00
Dec 31, 2023 363,426.00
Sep 30, 2023 6.12 Mn
Jun 30, 2023 104,869.00
Dec 31, 2022 -2,820.00
Sep 30, 2022 3,120.00
Jun 30, 2022 24,101.00
Dec 31, 2021 756,924.00
Sep 30, 2021 1.99 Mn
Jun 30, 2021 1.97 Mn
Mar 31, 2021 1.19 Mn